日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Catalytic Proximal Protein Oligomerization as an Anti-Tumor Strategy Targeting WDR5

以WDR5为靶点的催化近端蛋白寡聚化抗肿瘤策略

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-70409-z
Fang, Yizheng; Jiang, Li; Wang, Feifan; Zhou, Yihui; Cen, Jie; Yang, Yuxin; Wang, Haiyang; Chen, Qi; Lin, Yushen; Wang, Tingting; Xu, Hongxia; Yu, Yongping; Zhu, Chengliang; He, Qiaojun; Yang, Bo; Zhou, Chun; Chen, Wenteng; Tang, Longhua; Cao, Ji
肿瘤
肿瘤免疫
WDR5
发表日期：2026
文献求助 收藏

DJ-1 inhibition reshapes tumor microenvironment and potentiates immune checkpoint inhibitors

DJ-1抑制剂可重塑肿瘤微环境并增强免疫检查点抑制剂的疗效。

期刊:Science Advances
影响因子:12.5
doi:10.1126/sciadv.ady7556
Zhu, Haiying; Lin, Yushen; Jiang, Li; Zhao, Wenyi; Chen, Mengdie; Lu, Bin; Zhou, Zhan; He, Qiaojun; Yang, Bo; Tomek, Petr; Zhao, Wenbin; Cao, Ji
肿瘤
肿瘤免疫
肿瘤微环境
DJ-1
免疫/内分泌
发表日期：2026
文献求助 收藏

Tail-Latency-Aware Federated Learning with Pinching Antenna: Latency, Participation, and Placement

具有收缩天线的尾延迟感知联邦学习：延迟、参与度和位置

期刊:Entropy
影响因子:2
doi:10.3390/e28030341
Lin, Yushen; Ding, Zhiguo
发表日期：2026
文献求助 收藏

Discovery of a potential hematologic malignancies therapy: Selective and potent HDAC7 PROTAC degrader targeting non-enzymatic function.

发现一种潜在的血液恶性肿瘤疗法：选择性强效的 HDAC7 PROTAC 降解剂，靶向非酶功能

期刊:Acta Pharmaceutica Sinica B
影响因子:14.6
doi:10.1016/j.apsb.2025.01.021
Jin Yuheng, Qi Xuxin, Yu Xiaoli, Cheng Xirui, Chen Boya, Wu Mingfei, Zhang Jingyu, Yin Hao, Lu Yang, Zhou Yihui, Pang Ao, Lin Yushen, Jiang Li, Shi Qiuqiu, Geng Shuangshuang, Zhou Yubo, Yao Xiaojun, Li Linjie, Duan Haiting, Che Jinxin, Cao Ji, He Qiaojun, Dong Xiaowu
肿瘤
发表日期：2025
文献求助 收藏